Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE studyGiuseppe Lamberti, Andrea Ardizzoni, Francesca Mazzoni et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 5